nodes	percent_of_prediction	percent_of_DWPC	metapath
Codeine—SLC22A1—Cytarabine—lymphatic system cancer	0.292	0.35	CbGbCtD
Codeine—CYP3A5—Teniposide—lymphatic system cancer	0.135	0.162	CbGbCtD
Codeine—CYP3A7—Vincristine—lymphatic system cancer	0.0868	0.104	CbGbCtD
Codeine—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0868	0.104	CbGbCtD
Codeine—CYP3A5—Vincristine—lymphatic system cancer	0.0651	0.078	CbGbCtD
Codeine—CYP3A4—Cytarabine—lymphatic system cancer	0.0536	0.0642	CbGbCtD
Codeine—CYP3A4—Teniposide—lymphatic system cancer	0.0528	0.0632	CbGbCtD
Codeine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0369	0.0442	CbGbCtD
Codeine—CYP3A4—Vincristine—lymphatic system cancer	0.0254	0.0304	CbGbCtD
Codeine—Intracranial pressure increased—Carmustine—lymphatic system cancer	0.00437	0.0265	CcSEcCtD
Codeine—Abdominal cramps—Vincristine—lymphatic system cancer	0.00258	0.0156	CcSEcCtD
Codeine—Depression—Mechlorethamine—lymphatic system cancer	0.00246	0.0149	CcSEcCtD
Codeine—Visual disturbance—Fludarabine—lymphatic system cancer	0.00219	0.0132	CcSEcCtD
Codeine—Dehydration—Fludarabine—lymphatic system cancer	0.00193	0.0117	CcSEcCtD
Codeine—Loss of libido—Methotrexate—lymphatic system cancer	0.00183	0.0111	CcSEcCtD
Codeine—Sweating increased—Fludarabine—lymphatic system cancer	0.00174	0.0106	CcSEcCtD
Codeine—Sweating—Teniposide—lymphatic system cancer	0.00174	0.0105	CcSEcCtD
Codeine—Vertigo—Mechlorethamine—lymphatic system cancer	0.00173	0.0105	CcSEcCtD
Codeine—Flushing—Teniposide—lymphatic system cancer	0.00151	0.00916	CcSEcCtD
Codeine—Anorexia—Mechlorethamine—lymphatic system cancer	0.0015	0.00907	CcSEcCtD
Codeine—Polyuria—Vincristine—lymphatic system cancer	0.00144	0.00873	CcSEcCtD
Codeine—Visual impairment—Fludarabine—lymphatic system cancer	0.00138	0.00836	CcSEcCtD
Codeine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00137	0.00827	CcSEcCtD
Codeine—Diplopia—Carmustine—lymphatic system cancer	0.00133	0.00803	CcSEcCtD
Codeine—Agitation—Teniposide—lymphatic system cancer	0.0013	0.0079	CcSEcCtD
Codeine—Urinary retention—Vincristine—lymphatic system cancer	0.0012	0.00729	CcSEcCtD
Codeine—Cardiac arrest—Vincristine—lymphatic system cancer	0.0012	0.00729	CcSEcCtD
Codeine—Dehydration—Vincristine—lymphatic system cancer	0.00118	0.00713	CcSEcCtD
Codeine—Confusional state—Teniposide—lymphatic system cancer	0.00117	0.00707	CcSEcCtD
Codeine—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00116	0.00701	CcSEcCtD
Codeine—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00116	0.00701	CcSEcCtD
Codeine—Agitation—Fludarabine—lymphatic system cancer	0.00115	0.00694	CcSEcCtD
Codeine—Dehydration—Mitoxantrone—lymphatic system cancer	0.00115	0.00694	CcSEcCtD
Codeine—Tachycardia—Teniposide—lymphatic system cancer	0.00113	0.00685	CcSEcCtD
Codeine—Malaise—Fludarabine—lymphatic system cancer	0.00113	0.00681	CcSEcCtD
Codeine—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00112	0.00678	CcSEcCtD
Codeine—Pruritus—Mechlorethamine—lymphatic system cancer	0.00111	0.00673	CcSEcCtD
Codeine—Anorexia—Teniposide—lymphatic system cancer	0.0011	0.00669	CcSEcCtD
Codeine—Hypotension—Teniposide—lymphatic system cancer	0.00108	0.00656	CcSEcCtD
Codeine—Convulsion—Fludarabine—lymphatic system cancer	0.00108	0.00655	CcSEcCtD
Codeine—Discomfort—Fludarabine—lymphatic system cancer	0.00105	0.00635	CcSEcCtD
Codeine—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00104	0.00628	CcSEcCtD
Codeine—Dyspnoea—Teniposide—lymphatic system cancer	0.00103	0.00625	CcSEcCtD
Codeine—Confusional state—Fludarabine—lymphatic system cancer	0.00103	0.00622	CcSEcCtD
Codeine—Depression—Carmustine—lymphatic system cancer	0.00102	0.00617	CcSEcCtD
Codeine—Decreased appetite—Teniposide—lymphatic system cancer	0.00101	0.0061	CcSEcCtD
Codeine—Vomiting—Mechlorethamine—lymphatic system cancer	0.000999	0.00605	CcSEcCtD
Codeine—Nervous system disorder—Fludarabine—lymphatic system cancer	0.000999	0.00605	CcSEcCtD
Codeine—Rash—Mechlorethamine—lymphatic system cancer	0.000991	0.006	CcSEcCtD
Codeine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00099	0.00599	CcSEcCtD
Codeine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.000985	0.00596	CcSEcCtD
Codeine—Flushing—Bleomycin—lymphatic system cancer	0.000975	0.00591	CcSEcCtD
Codeine—Depression—Vincristine—lymphatic system cancer	0.000973	0.00589	CcSEcCtD
Codeine—Anorexia—Fludarabine—lymphatic system cancer	0.000971	0.00588	CcSEcCtD
Codeine—Feeling abnormal—Teniposide—lymphatic system cancer	0.000955	0.00578	CcSEcCtD
Codeine—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00095	0.00575	CcSEcCtD
Codeine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000948	0.00574	CcSEcCtD
Codeine—Bone disorder—Methotrexate—lymphatic system cancer	0.000937	0.00567	CcSEcCtD
Codeine—Sweating—Vincristine—lymphatic system cancer	0.000935	0.00566	CcSEcCtD
Codeine—Nausea—Mechlorethamine—lymphatic system cancer	0.000934	0.00565	CcSEcCtD
Codeine—Urticaria—Teniposide—lymphatic system cancer	0.000921	0.00557	CcSEcCtD
Codeine—Abdominal pain—Teniposide—lymphatic system cancer	0.000916	0.00555	CcSEcCtD
Codeine—Body temperature increased—Teniposide—lymphatic system cancer	0.000916	0.00555	CcSEcCtD
Codeine—Erythema—Bleomycin—lymphatic system cancer	0.000915	0.00554	CcSEcCtD
Codeine—Hallucination—Carmustine—lymphatic system cancer	0.000913	0.00553	CcSEcCtD
Codeine—Sweating—Mitoxantrone—lymphatic system cancer	0.000911	0.00551	CcSEcCtD
Codeine—Dyspnoea—Fludarabine—lymphatic system cancer	0.000908	0.0055	CcSEcCtD
Codeine—Decreased appetite—Fludarabine—lymphatic system cancer	0.000885	0.00536	CcSEcCtD
Codeine—Visual impairment—Carmustine—lymphatic system cancer	0.000884	0.00535	CcSEcCtD
Codeine—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000879	0.00532	CcSEcCtD
Codeine—Fatigue—Fludarabine—lymphatic system cancer	0.000878	0.00532	CcSEcCtD
Codeine—Hallucination—Vincristine—lymphatic system cancer	0.000871	0.00528	CcSEcCtD
Codeine—Constipation—Fludarabine—lymphatic system cancer	0.000871	0.00527	CcSEcCtD
Codeine—Bradycardia—Mitoxantrone—lymphatic system cancer	0.000868	0.00526	CcSEcCtD
Codeine—Urinary tract disorder—Vincristine—lymphatic system cancer	0.000865	0.00524	CcSEcCtD
Codeine—Urethral disorder—Vincristine—lymphatic system cancer	0.000859	0.0052	CcSEcCtD
Codeine—Eye disorder—Carmustine—lymphatic system cancer	0.000857	0.00519	CcSEcCtD
Codeine—Hypersensitivity—Teniposide—lymphatic system cancer	0.000854	0.00517	CcSEcCtD
Codeine—Flushing—Carmustine—lymphatic system cancer	0.000851	0.00515	CcSEcCtD
Codeine—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000849	0.00514	CcSEcCtD
Codeine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000839	0.00508	CcSEcCtD
Codeine—Asthenia—Teniposide—lymphatic system cancer	0.000831	0.00503	CcSEcCtD
Codeine—Malaise—Bleomycin—lymphatic system cancer	0.000825	0.005	CcSEcCtD
Codeine—Pruritus—Teniposide—lymphatic system cancer	0.00082	0.00496	CcSEcCtD
Codeine—Cardiac disorder—Vincristine—lymphatic system cancer	0.000813	0.00492	CcSEcCtD
Codeine—Body temperature increased—Fludarabine—lymphatic system cancer	0.000805	0.00487	CcSEcCtD
Codeine—Erythema—Carmustine—lymphatic system cancer	0.000799	0.00484	CcSEcCtD
Codeine—Mediastinal disorder—Vincristine—lymphatic system cancer	0.000789	0.00478	CcSEcCtD
Codeine—Discomfort—Bleomycin—lymphatic system cancer	0.00077	0.00466	CcSEcCtD
Codeine—Confusional state—Bleomycin—lymphatic system cancer	0.000753	0.00456	CcSEcCtD
Codeine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00075	0.00454	CcSEcCtD
Codeine—Tremor—Carmustine—lymphatic system cancer	0.000748	0.00453	CcSEcCtD
Codeine—Erythema—Mitoxantrone—lymphatic system cancer	0.000742	0.0045	CcSEcCtD
Codeine—Vomiting—Teniposide—lymphatic system cancer	0.000737	0.00446	CcSEcCtD
Codeine—Agitation—Carmustine—lymphatic system cancer	0.000734	0.00444	CcSEcCtD
Codeine—Asthenia—Fludarabine—lymphatic system cancer	0.000731	0.00442	CcSEcCtD
Codeine—Rash—Teniposide—lymphatic system cancer	0.000731	0.00442	CcSEcCtD
Codeine—Dermatitis—Teniposide—lymphatic system cancer	0.00073	0.00442	CcSEcCtD
Codeine—Pruritus—Fludarabine—lymphatic system cancer	0.000721	0.00436	CcSEcCtD
Codeine—Anorexia—Bleomycin—lymphatic system cancer	0.000712	0.00431	CcSEcCtD
Codeine—Agitation—Vincristine—lymphatic system cancer	0.000701	0.00424	CcSEcCtD
Codeine—Polyuria—Methotrexate—lymphatic system cancer	0.0007	0.00424	CcSEcCtD
Codeine—Hypotension—Bleomycin—lymphatic system cancer	0.000698	0.00422	CcSEcCtD
Codeine—Convulsion—Carmustine—lymphatic system cancer	0.000692	0.00419	CcSEcCtD
Codeine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000689	0.00417	CcSEcCtD
Codeine—Nausea—Teniposide—lymphatic system cancer	0.000688	0.00417	CcSEcCtD
Codeine—Vertigo—Vincristine—lymphatic system cancer	0.000685	0.00415	CcSEcCtD
Codeine—Anxiety—Carmustine—lymphatic system cancer	0.000678	0.0041	CcSEcCtD
Codeine—Malaise—Mitoxantrone—lymphatic system cancer	0.00067	0.00405	CcSEcCtD
Codeine—Dyspnoea—Bleomycin—lymphatic system cancer	0.000666	0.00403	CcSEcCtD
Codeine—Convulsion—Vincristine—lymphatic system cancer	0.000661	0.004	CcSEcCtD
Codeine—Confusional state—Carmustine—lymphatic system cancer	0.000657	0.00398	CcSEcCtD
Codeine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000649	0.00393	CcSEcCtD
Codeine—Visual disturbance—Methotrexate—lymphatic system cancer	0.000648	0.00392	CcSEcCtD
Codeine—Vomiting—Fludarabine—lymphatic system cancer	0.000648	0.00392	CcSEcCtD
Codeine—Convulsion—Mitoxantrone—lymphatic system cancer	0.000643	0.00389	CcSEcCtD
Codeine—Rash—Fludarabine—lymphatic system cancer	0.000642	0.00389	CcSEcCtD
Codeine—Dermatitis—Fludarabine—lymphatic system cancer	0.000642	0.00388	CcSEcCtD
Codeine—Tachycardia—Carmustine—lymphatic system cancer	0.000636	0.00385	CcSEcCtD
Codeine—Anxiety—Mitoxantrone—lymphatic system cancer	0.00063	0.00381	CcSEcCtD
Codeine—Discomfort—Mitoxantrone—lymphatic system cancer	0.000625	0.00378	CcSEcCtD
Codeine—Anorexia—Carmustine—lymphatic system cancer	0.000621	0.00376	CcSEcCtD
Codeine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000615	0.00373	CcSEcCtD
Codeine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000611	0.0037	CcSEcCtD
Codeine—Nervous system disorder—Vincristine—lymphatic system cancer	0.00061	0.00369	CcSEcCtD
Codeine—Hypotension—Carmustine—lymphatic system cancer	0.000609	0.00369	CcSEcCtD
Codeine—Nausea—Fludarabine—lymphatic system cancer	0.000605	0.00366	CcSEcCtD
Codeine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000602	0.00364	CcSEcCtD
Codeine—Shock—Mitoxantrone—lymphatic system cancer	0.000596	0.00361	CcSEcCtD
Codeine—Urticaria—Bleomycin—lymphatic system cancer	0.000593	0.00359	CcSEcCtD
Codeine—Anorexia—Vincristine—lymphatic system cancer	0.000593	0.00359	CcSEcCtD
Codeine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000591	0.00358	CcSEcCtD
Codeine—Body temperature increased—Bleomycin—lymphatic system cancer	0.00059	0.00357	CcSEcCtD
Codeine—Insomnia—Carmustine—lymphatic system cancer	0.00059	0.00357	CcSEcCtD
Codeine—Irritability—Methotrexate—lymphatic system cancer	0.000586	0.00355	CcSEcCtD
Codeine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000586	0.00355	CcSEcCtD
Codeine—Mood swings—Methotrexate—lymphatic system cancer	0.000582	0.00352	CcSEcCtD
Codeine—Hypotension—Vincristine—lymphatic system cancer	0.000581	0.00352	CcSEcCtD
Codeine—Dyspnoea—Carmustine—lymphatic system cancer	0.000581	0.00352	CcSEcCtD
Codeine—Somnolence—Carmustine—lymphatic system cancer	0.000579	0.00351	CcSEcCtD
Codeine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000578	0.0035	CcSEcCtD
Codeine—Decreased appetite—Carmustine—lymphatic system cancer	0.000567	0.00343	CcSEcCtD
Codeine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000566	0.00343	CcSEcCtD
Codeine—Insomnia—Vincristine—lymphatic system cancer	0.000563	0.00341	CcSEcCtD
Codeine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000563	0.00341	CcSEcCtD
Codeine—Constipation—Carmustine—lymphatic system cancer	0.000557	0.00337	CcSEcCtD
Codeine—Breast disorder—Methotrexate—lymphatic system cancer	0.000555	0.00336	CcSEcCtD
Codeine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00055	0.00333	CcSEcCtD
Codeine—Decreased appetite—Vincristine—lymphatic system cancer	0.000541	0.00327	CcSEcCtD
Codeine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00054	0.00327	CcSEcCtD
Codeine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000539	0.00326	CcSEcCtD
Codeine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000537	0.00325	CcSEcCtD
Codeine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000537	0.00325	CcSEcCtD
Codeine—Fatigue—Vincristine—lymphatic system cancer	0.000536	0.00325	CcSEcCtD
Codeine—Asthenia—Bleomycin—lymphatic system cancer	0.000536	0.00324	CcSEcCtD
Codeine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000533	0.00323	CcSEcCtD
Codeine—Constipation—Vincristine—lymphatic system cancer	0.000532	0.00322	CcSEcCtD
Codeine—Pruritus—Bleomycin—lymphatic system cancer	0.000528	0.0032	CcSEcCtD
Codeine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000527	0.00319	CcSEcCtD
Codeine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000522	0.00316	CcSEcCtD
Codeine—Pancreatitis—Methotrexate—lymphatic system cancer	0.000521	0.00315	CcSEcCtD
Codeine—Constipation—Mitoxantrone—lymphatic system cancer	0.000518	0.00314	CcSEcCtD
Codeine—Abdominal pain—Carmustine—lymphatic system cancer	0.000515	0.00312	CcSEcCtD
Codeine—Body temperature increased—Carmustine—lymphatic system cancer	0.000515	0.00312	CcSEcCtD
Codeine—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000509	0.00308	CcSEcCtD
Codeine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000509	0.00308	CcSEcCtD
Codeine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000499	0.00302	CcSEcCtD
Codeine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000496	0.003	CcSEcCtD
Codeine—Abdominal pain—Vincristine—lymphatic system cancer	0.000492	0.00298	CcSEcCtD
Codeine—Body temperature increased—Vincristine—lymphatic system cancer	0.000492	0.00298	CcSEcCtD
Codeine—Urticaria—Mitoxantrone—lymphatic system cancer	0.000481	0.00291	CcSEcCtD
Codeine—Hypersensitivity—Carmustine—lymphatic system cancer	0.00048	0.00291	CcSEcCtD
Codeine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000479	0.0029	CcSEcCtD
Codeine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000479	0.0029	CcSEcCtD
Codeine—Vomiting—Bleomycin—lymphatic system cancer	0.000475	0.00287	CcSEcCtD
Codeine—Drowsiness—Methotrexate—lymphatic system cancer	0.000473	0.00287	CcSEcCtD
Codeine—Depression—Methotrexate—lymphatic system cancer	0.000472	0.00286	CcSEcCtD
Codeine—Rash—Bleomycin—lymphatic system cancer	0.000471	0.00285	CcSEcCtD
Codeine—Dermatitis—Bleomycin—lymphatic system cancer	0.00047	0.00285	CcSEcCtD
Codeine—Asthenia—Carmustine—lymphatic system cancer	0.000468	0.00283	CcSEcCtD
Codeine—Hypersensitivity—Vincristine—lymphatic system cancer	0.000458	0.00278	CcSEcCtD
Codeine—Sweating—Methotrexate—lymphatic system cancer	0.000454	0.00275	CcSEcCtD
Codeine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000446	0.0027	CcSEcCtD
Codeine—Asthenia—Vincristine—lymphatic system cancer	0.000446	0.0027	CcSEcCtD
Codeine—Nausea—Bleomycin—lymphatic system cancer	0.000444	0.00269	CcSEcCtD
Codeine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000435	0.00263	CcSEcCtD
Codeine—Dizziness—Carmustine—lymphatic system cancer	0.000431	0.00261	CcSEcCtD
Codeine—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00042	0.00254	CcSEcCtD
Codeine—Urethral disorder—Methotrexate—lymphatic system cancer	0.000417	0.00252	CcSEcCtD
Codeine—Vomiting—Carmustine—lymphatic system cancer	0.000414	0.00251	CcSEcCtD
Codeine—Dizziness—Vincristine—lymphatic system cancer	0.000411	0.00249	CcSEcCtD
Codeine—Rash—Carmustine—lymphatic system cancer	0.000411	0.00249	CcSEcCtD
Codeine—Dermatitis—Carmustine—lymphatic system cancer	0.000411	0.00249	CcSEcCtD
Codeine—Visual impairment—Methotrexate—lymphatic system cancer	0.00041	0.00248	CcSEcCtD
Codeine—Eye disorder—Methotrexate—lymphatic system cancer	0.000397	0.0024	CcSEcCtD
Codeine—Vomiting—Vincristine—lymphatic system cancer	0.000396	0.0024	CcSEcCtD
Codeine—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000394	0.00239	CcSEcCtD
Codeine—Rash—Vincristine—lymphatic system cancer	0.000392	0.00238	CcSEcCtD
Codeine—Dermatitis—Vincristine—lymphatic system cancer	0.000392	0.00237	CcSEcCtD
Codeine—Nausea—Carmustine—lymphatic system cancer	0.000387	0.00234	CcSEcCtD
Codeine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000385	0.00233	CcSEcCtD
Codeine—Immune system disorder—Methotrexate—lymphatic system cancer	0.000384	0.00232	CcSEcCtD
Codeine—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000383	0.00232	CcSEcCtD
Codeine—Rash—Mitoxantrone—lymphatic system cancer	0.000382	0.00231	CcSEcCtD
Codeine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000382	0.00231	CcSEcCtD
Codeine—Erythema—Methotrexate—lymphatic system cancer	0.00037	0.00224	CcSEcCtD
Codeine—Nausea—Vincristine—lymphatic system cancer	0.00037	0.00224	CcSEcCtD
Codeine—Nausea—Mitoxantrone—lymphatic system cancer	0.00036	0.00218	CcSEcCtD
Codeine—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000343	0.00208	CcSEcCtD
Codeine—Malaise—Methotrexate—lymphatic system cancer	0.000334	0.00202	CcSEcCtD
Codeine—Vertigo—Methotrexate—lymphatic system cancer	0.000332	0.00201	CcSEcCtD
Codeine—Convulsion—Methotrexate—lymphatic system cancer	0.000321	0.00194	CcSEcCtD
Codeine—Discomfort—Methotrexate—lymphatic system cancer	0.000311	0.00188	CcSEcCtD
Codeine—Confusional state—Methotrexate—lymphatic system cancer	0.000304	0.00184	CcSEcCtD
Codeine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000296	0.00179	CcSEcCtD
Codeine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000292	0.00177	CcSEcCtD
Codeine—Anorexia—Methotrexate—lymphatic system cancer	0.000288	0.00174	CcSEcCtD
Codeine—Hypotension—Methotrexate—lymphatic system cancer	0.000282	0.00171	CcSEcCtD
Codeine—Insomnia—Methotrexate—lymphatic system cancer	0.000273	0.00165	CcSEcCtD
Codeine—Dyspnoea—Methotrexate—lymphatic system cancer	0.000269	0.00163	CcSEcCtD
Codeine—Somnolence—Methotrexate—lymphatic system cancer	0.000268	0.00162	CcSEcCtD
Codeine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000262	0.00159	CcSEcCtD
Codeine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000261	0.00158	CcSEcCtD
Codeine—Fatigue—Methotrexate—lymphatic system cancer	0.00026	0.00158	CcSEcCtD
Codeine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000249	0.00151	CcSEcCtD
Codeine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000247	0.00149	CcSEcCtD
Codeine—Urticaria—Methotrexate—lymphatic system cancer	0.00024	0.00145	CcSEcCtD
Codeine—Abdominal pain—Methotrexate—lymphatic system cancer	0.000239	0.00144	CcSEcCtD
Codeine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000239	0.00144	CcSEcCtD
Codeine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000222	0.00135	CcSEcCtD
Codeine—Asthenia—Methotrexate—lymphatic system cancer	0.000217	0.00131	CcSEcCtD
Codeine—Pruritus—Methotrexate—lymphatic system cancer	0.000214	0.00129	CcSEcCtD
Codeine—Dizziness—Methotrexate—lymphatic system cancer	0.0002	0.00121	CcSEcCtD
Codeine—Vomiting—Methotrexate—lymphatic system cancer	0.000192	0.00116	CcSEcCtD
Codeine—Rash—Methotrexate—lymphatic system cancer	0.00019	0.00115	CcSEcCtD
Codeine—Dermatitis—Methotrexate—lymphatic system cancer	0.00019	0.00115	CcSEcCtD
Codeine—Nausea—Methotrexate—lymphatic system cancer	0.000179	0.00109	CcSEcCtD
